Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Formulation
6.1.1 Liquid
6.1.1.1 Solution
6.1.1.2 Suspension
6.1.2 Semi-Solid
6.1.2.1 Ointment
6.1.2.2 Gel
6.1.2.3 Paste
6.1.2.4 Cream & Lotion
6.1.3 Solid
6.1.3.1 Powder
6.2 Device
6.2.1 Patch
6.2.2 Inhaler
Chapter 7 Market Segmentation by route of Administration
7.1 Vaginal
7.2 Oral topical
7.3 Ophthalmic
7.4 Nasal
7.5 Dermal
7.6 Others
Chapter 8 Market Segmentation by Facility Use
8.1 Hospitals
8.2 Private Clinics
8.3 Home Care Settings
8.4 Others
Chapter 9 Market Segmentation by Geography
9.1 Asia Pacific
9.1.1 Introduction
9.1.2 China
9.1.3 India
9.1.4 Japan
9.1.5 Australia & New Zealand
9.1.6 Others
9.2 North America
9.2.1 Introduction
9.2.2 United States
9.2.3 Canada
9.2.4 Mexico
9.2.5 Others
9.3 Europe
9.3.1 Introduction
9.3.2 Spain
9.3.3 UK
9.3.4 France
9.3.5 Russia
9.3.6 Italy
9.3.7 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.4 Others
Chapter 10 Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3 Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 Business Overview
11.1.2 Product portfolio
11.1.3 Key Strategy
11.1.4 Recent Developments
11.2 Galderma
11.3 Crescita Therapeutics
11.4 Bayer
11.5 Janssen Global Services, LLC.
11.6 Valeant Pharmaceuticals
11.7 Cipla
11.8 Novartis
11.9 Biofarmitalia S.R.L
11.10 Medpharm
11.11 Endo Pharmaceuticals Inc.
11.12 Hisamitsu Pharmaceuticals
11.13 Lohmann Therapie-Systeme AG
11.14 Johnson & Johnson
11.15 Solvay
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Product 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecast by Route of Administration 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecast by Facility of Use 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
